Clinics Mi and Vitalera: Innovating in Oncological Care with Remote Patient monitoring

Clinics Mi and Vitalera have signed a collaboration agreement to support oncology patients throughout their treatment, from any location, 24 hours a day, 365 days a year. This alliance promises to revolutionize the way cancer patients are cared for by integrating advanced telemedicine and patient telemonitoring technology to offer more personalized and effective care.

The Importance of Rempte Patient Monitoring and Oncology:

Patient telemonitoring has become an essential tool in modern medical care, especially in oncology. This technology allows for continuous and detailed monitoring of the patient's vital signs, providing doctors with the necessary information to make informed and timely decisions.

Advantages of Telemedicine:

1. Personalized Monitoring: Vitalera's AI-based solution facilitates personalized monitoring of each patient, adapting to their individual needs. This is crucial in oncology, where each case can be very different.

2. Continuous Access to Vital Data: Professionals at UOMi Cancer Center can access the patient's vital signs at any time, even without an explicit request from the patient. This allows for early intervention if any anomaly is detected.

3. Comprehensive Support: In addition to monitoring physical indicators, telemonitoring allows for tracking the patient's emotional state and medication, ensuring a comprehensive approach to treatment.

Dr. Santiago Viteri, director of UOMi Cancer Center, highlights that, “Doctors, in addition to accessing vital indicators with or without an express request from the patient, monitor medication and the emotional state of each patient, which allows us to make relevant treatment decisions at any time, and much better informed than before.”

Implementation in Clinics Mi:

Professionals at UOMi Cancer Center have been working with Vitalera’s solution for a year, providing services at the Mi Tres Torres clinic in Barcelona and Mi NovAliança in Lleida. This intelligent support and decision-making system for oncology has proven invaluable. Through this solution, the patient can share their condition at any time with the professional, and better yet: the doctor can anticipate and act before doubts and anxiety arise in the patient.

Experience at Mi Tres Torres Clinic:

At the Mi Tres Torres clinic in Barcelona, the service was inaugurated with very positive results. Patients have reported an improvement in their quality of life thanks to constant monitoring and the ability to immediately resolve their doubts through consultations enabled via chat or video calls.

Expansion to Mi NovAliança:

Following the positive results in the Catalan capital, the solution is expected to begin implementation at Mi NovAliança (Lleida) during this quarter. This move underscores Clinics Mi's commitment to innovation and continuous improvement in oncological care.

Delivering what patient's need next:

Telemedicine complements patient telemonitoring by enabling remote consultations between the patient and their doctor. This technology reduces the need for travel, which is especially beneficial for cancer patients who may have reduced mobility or be immunocompromised.

Why the use of Telemedicine?

1. Accessibility: Telemedicine removes geographical barriers, allowing patients to receive specialist medical care regardless of their location.

2. Convenience: Patients can have consultations from the comfort of their home, reducing the stress and discomfort of frequent hospital visits.

3. Quick Response: The ability to enable consultations through chat or video calls allows for a quick response to any new concern or symptom the patient may experience.

Núria Pastor, CEO of Vitalera, commented on the alliance: “We are very happy about this alliance with Clinics Mi, to offer more personalized health care to the oncology patients of Clinics Mi in the Catalan region and to be able to bring care to the patients' homes. During the past year, patients, families, and doctors have successfully embraced the solution, and now we only hope to continue adding value to medical care.”

A Promising Future for Oncology

The agreement between Clinics Mi and Vitalera, initially set for three years, includes an exclusivity clause in oncology and the Catalan region. This means that only Clinics Mi centers will be able to offer this innovative cancer patient monitoring service, ensuring that their patients receive the highest standard of care.

The combination of patient telemonitoring and telemedicine not only improves the quality of life for oncology patients but also provides doctors with advanced tools for more precise and personalized monitoring. This comprehensive approach ensures that patients receive continuous and effective care, anticipating their needs and providing support at all times.

The partnership between Clinics Mi and Vitalera represents a significant advance in the field of oncology, demonstrating how technology can transform medical care and improve patients' lives. With the implementation of these innovative solutions, the future of oncological care looks promising, offering patients the possibility of facing their illness with greater confidence and peace of mind.